Clinical Trials in Atlanta

Showing 12221-12240 of 19,805 trials

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

NCT02567656

The purpose of this study is to evaluate the safety, PK and efficacy of RP6530, a dual PI3K delta/gamma inhibitor in patients with relapsed and refractory T-cell Lymphoma.

Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous

Rhizen Pharmaceuticals SA58 participantsStarted Sep 2015

Duarte, California, United States • Orange, California, United States • Aurora, Colorado, United States +5 more locations

COMPLETED< 1 mile

Answer ALS: Individualized Initiative for ALS Discovery

NCT02574390

Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more

Johns Hopkins University1,049 participantsStarted Dec 2015

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Answer ALS: Individualized Initiative for ALS Discovery

Find Trials by Condition in Atlanta

Safety of PDT-Photofrin® Prior to Lung Surgery

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

FACBC Prostate Therapy Response

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

Performance Assessment of a Modified Daily Disposable Contact Lens

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Radiesse® Safety Study For the Treatment of Hands

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia